Suzuki, K., Claggett, B., Minamisawa, M., Packer, M., Zile, M. R., Rouleau, J., … Solomon, S. D. (2020). Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction. European Journal of Heart Failure, 22(9), 1662–1671. https://doi.org/10.1002/ejhf.1853

Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, Milton Packer, Michael R. Zile, Jean Rouleau, Karl Swedberg, et al. “Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.” European Journal of Heart Failure 22, no. 9 (September 2020): 1662–71. https://doi.org/10.1002/ejhf.1853.

Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Rouleau J, et al. Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction. European Journal of Heart Failure. 2020 Sep;22(9):1662–71.

Suzuki, Kota, et al. “Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.” European Journal of Heart Failure, vol. 22, no. 9, Oxford University Press (OUP), Sept. 2020, pp. 1662–71. Crossref, doi:10.1002/ejhf.1853.

Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Rouleau J, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Zucker SD, Solomon SD. Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction. European Journal of Heart Failure. Oxford University Press (OUP); 2020 Sep;22(9):1662–1671.